Open AccessTransanal total mesorectal excision oncological results
Author(s) -
Lyudmila Kazieva,
С. В. Чернышов,
Yuliya Alimova,
Е. Г. Рыбаков
Publication year - 2022
Publication title -
voprosy onkologii
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.108
H-Index - 11
eISSN - 2949-4915
pISSN - 0507-3758
DOI - 10.37469/0507-3758-2022-68-2-200-208
Subject(s) - medicine , total mesorectal excision , colorectal cancer , surgery , mesorectum , stage (stratigraphy) , metastasis , life expectancy , distant metastasis , cancer , population , paleontology , environmental health , biology
Relevance. Transanal total mesorectal is a new surgical technique of rectal cancer treatment.Purpose of research. To evaluate transanal total mesorectal excision oncological results.Materials and methods. 66 patients with rectal cancer I–IV stage were included.Results. Median follow-up was 42.9±22.8 (1–83.7) months. Progression of the disease was in 13 (19.7%) cases. Local recurrence rate was 5 (7.6%) with mean time to recurrence 14.2±11.3 (5–32.3) months. Distant metastasis was diagnosed in 10 (15.2%) cases, mean time when they were diagnosed was 15.04±12.09 (3.5–37.5) months. Combination of local recurrences and distant metastasis was in 2 (3%) cases. Seven (10.6%) patients died. Mean life expectancy was 27.3±17.2 (8.0–50.2) months. Five (7.5%) patients died because of progression of oncological disease. Mean life expectancy was 34.11±15.5 (15.5–50.2) months. Six-year local recurrence free, disease free and overall survival was 77, 87 и 84%, respectively. No risk factors of local recurrence were found.Conclusion. Transanal total mesorectal excision oncological results are сomparable with conventional surgery, though further trials are necessary.